Nidek Incorporated

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$22Kgeneral payments (2019-2025)
$4,951research payments (2019-2025)
5clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $18K
2020 $0.00
2021 $3,693

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Ophthalmology $13K
Uveitis and Ocular Inflammatory Disease $4,938
Hospitalist $3,492

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Leonard Ginsburg Springfield, PA Ophthalmology $8,143.49
Nadia Waheed Boston, MA Uveitis and Ocular Inflammatory Disease $4,937.50
James Lewis Elkins Park, PA Ophthalmology $4,117.03
Sri Krishna Mukkamala Cumming, GA Hospitalist $3,492.18
Steven Stetson New York, NY Ophthalmology $1,000.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.